JMP Securities Reaffirms “Market Perform” Rating for Ryan Specialty (NYSE:RYAN)

JMP Securities reiterated their market perform rating on shares of Ryan Specialty (NYSE:RYANFree Report) in a research report sent to investors on Monday morning, Benzinga reports.

Other research analysts also recently issued reports about the stock. Wells Fargo & Company upped their target price on shares of Ryan Specialty from $57.00 to $58.00 and gave the company an overweight rating in a research report on Thursday, April 11th. Citigroup upped their price target on Ryan Specialty from $49.00 to $52.00 and gave the company a neutral rating in a research note on Wednesday, February 28th. Keefe, Bruyette & Woods upped their price target on Ryan Specialty from $56.00 to $62.00 and gave the company an outperform rating in a research note on Wednesday, April 10th. Finally, JPMorgan Chase & Co. upped their price target on Ryan Specialty from $47.00 to $49.00 and gave the company an underweight rating in a research note on Monday, April 8th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of Hold and an average target price of $54.25.

Check Out Our Latest Stock Analysis on RYAN

Ryan Specialty Stock Performance

Ryan Specialty stock opened at $50.30 on Monday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 1.98. Ryan Specialty has a 1 year low of $39.44 and a 1 year high of $56.51. The company has a market cap of $13.09 billion, a PE ratio of 98.63 and a beta of 0.52. The company’s 50-day moving average is $51.24 and its two-hundred day moving average is $46.84.

Ryan Specialty (NYSE:RYANGet Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.35 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.35. Ryan Specialty had a net margin of 9.36% and a return on equity of 44.84%. The company had revenue of $532.90 million for the quarter, compared to the consensus estimate of $524.08 million. During the same period in the prior year, the company posted $0.27 EPS. The company’s revenue was up 22.5% compared to the same quarter last year. Equities analysts anticipate that Ryan Specialty will post 1.77 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a None dividend, which was paid on Wednesday, March 27th. Stockholders of record on Wednesday, March 13th were paid a dividend of $0.34 per share. The ex-dividend date was Tuesday, March 12th. Ryan Specialty’s dividend payout ratio is currently 86.27%.

Institutional Investors Weigh In On Ryan Specialty

Several large investors have recently made changes to their positions in RYAN. PNC Financial Services Group Inc. boosted its holdings in shares of Ryan Specialty by 192.0% in the 3rd quarter. PNC Financial Services Group Inc. now owns 549 shares of the company’s stock valued at $27,000 after buying an additional 361 shares during the last quarter. Royal Bank of Canada boosted its holdings in shares of Ryan Specialty by 524.8% in the 1st quarter. Royal Bank of Canada now owns 781 shares of the company’s stock valued at $31,000 after buying an additional 656 shares during the last quarter. Comerica Bank acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at approximately $34,000. Parkside Financial Bank & Trust boosted its holdings in shares of Ryan Specialty by 1,283.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,010 shares of the company’s stock valued at $43,000 after buying an additional 937 shares during the last quarter. Finally, American International Group Inc. acquired a new stake in shares of Ryan Specialty in the 2nd quarter valued at approximately $50,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.